Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics, DPC Lebanon Ink Pact to Distribute Colorectal Cancer MDx in Middle East

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Epigenomics today announced an exclusive agreement with DPC Lebanon for the distribution of the Epi proColon colorectal cancer test in parts of the Middle East.

Under the agreement, DPC Lebanon will distribute the test for the early detection of colorectal cancer in blood in Lebanon, the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Syria, Jordan, and Egypt.

Financial terms were not disclosed.

Epigenomics last month inked a deal for distribution of the test in Israel with Pronto and in Turkey with Dateks. Today's deal "completes the picture for the Middle East," Geert Nygaard, CEO of Epigenomics, said in a statement. "DPC will join Dateks and Pronto as important partners in our continuously growing distributor network for our Epi proColon product."

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.